Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.66B |
| 2 |
Amazon
AMZN
|
+$421M |
| 3 |
Citigroup
C
|
+$386M |
| 4 |
Wells Fargo
WFC
|
+$288M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.18B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.45B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.45B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$533M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$503M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.99% |
| 2 | Technology | 1.99% |
| 3 | Consumer Discretionary | 1.08% |
| 4 | Financials | 1% |
| 5 | Communication Services | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
CALL
Globus Medical
GMED
$11.1B
| $6.71M | ﹤0.01% |
135,600
+43,200
| +47% | +$2.23M |
|
|
WMGI
2677
PUT
DELISTED
Wright Medical Group Inc
WMGI
| $6.71M | ﹤0.01% |
219,600
+102,100
| +87% | +$3.08M |
|
2678
PUT
Albertsons Companies
ACI
$6.08B
| $6.7M | ﹤0.01% |
+484,000
| New | +$7.06M |
|
|
INFO
2679
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $6.7M | ﹤0.01% |
85,367
+78,363
| +1,119% | +$6.24M |
|
2680
PUT
BorgWarner
BWA
$13.1B
| $6.7M | ﹤0.01% |
196,414
-58,391
| -23% | -$2.01M |
|
2681
CALL
Stepan Co
SCL
$1.42B
| $6.68M | ﹤0.01% |
61,300
+4,300
| +8% | +$470K |
|
2682
PUT
SL Green Realty
SLG
$4.08B
| $6.67M | ﹤0.01% |
148,651
-18,078
| -11% | -$838K |
|
2683
CALL
iShares MSCI Taiwan ETF
EWT
$11.7B
| $6.66M | ﹤0.01% |
148,400
+142,800
| +2,550% | +$6.32M |
|
2684
CALL
Main Street Capital
MAIN
$5.47B
| $6.66M | ﹤0.01% |
225,300
-120,300
| -35% | -$3.69M |
|
2685
CALL
Dillards
DDS
$9.69B
| $6.66M | ﹤0.01% |
182,400
-19,400
| -10% | -$545K |
|
2686
XPO
XPO
$22.1B
| $6.66M | ﹤0.01% |
227,411
+176,924
| +350% | +$5.09M |
|
|
DCPH
2687
PUT
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $6.64M | ﹤0.01% |
129,400
+7,300
| +6% | +$358K |
|
2688
Baxter International
BAX
$13.5B
| $6.64M | ﹤0.01% |
82,531
-18,966
| -19% | -$1.6M |
|
2689
PUT
WEX
WEX
$6.72B
| $6.63M | ﹤0.01% |
47,700
-74,300
| -61% | -$11.6M |
|
2690
CRISPR Therapeutics
CRSP
$5.58B
| $6.6M | ﹤0.01% |
78,961
-105,081
| -57% | -$9.32M |
|
2691
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
| $6.6M | ﹤0.01% |
81,665
+49,322
| +152% | +$3.99M |
|
|
BBL
2692
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $6.6M | ﹤0.01% |
154,729
-51,393
| -25% | -$2.29M |
|
2693
PUT
Helen of Troy
HELE
$667M
| $6.6M | ﹤0.01% |
34,100
+12,500
| +58% | +$2.48M |
|
|
RETA
2694
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $6.59M | ﹤0.01% |
67,700
-32,400
| -32% | -$4.05M |
|
2695
Ingersoll Rand
IR
$30.5B
| $6.59M | ﹤0.01% |
185,057
-277,693
| -60% | -$9.3M |
|
2696
CALL
Red Rock Resorts
RRR
$3.37B
| $6.58M | ﹤0.01% |
384,800
+296,100
| +334% | +$4.31M |
|
2697
PUT
Wabtec
WAB
$49.4B
| $6.58M | ﹤0.01% |
106,300
-102,300
| -49% | -$6.56M |
|
2698
Ametek
AME
$54.2B
| $6.57M | ﹤0.01% |
66,079
-32,145
| -33% | -$3.11M |
|
2699
iShares Semiconductor ETF
SOXX
$41.5B
| $6.56M | ﹤0.01% |
64,620
-20,457
| -24% | -$2M |
|
2700
CALL
AerCap
AER
$23.2B
| $6.55M | ﹤0.01% |
260,100
+17,600
| +7% | +$510K |
|
Similar funds
Jeff Yass's Q3 2020 Portfolio in Review
As of Q3 2020, Jeff Yass held 11,604 positions worth $522B, up 26% from $415B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jeff Yass's Q3 2020 filing shows 1,567 new, 4,405 increased, 4,403 reduced and 1,138 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,104,687 shares worth $284M. The largest sale was Invesco QQQ Trust, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,104,687 shares worth $284M.
- Jeff Yass added most to Apple in Q3 2020, an estimated $2.66B increase.
- Jeff Yass's biggest Q3 2020 reduction was Invesco QQQ Trust, cutting an estimated $3.18B.
- Jeff Yass fully exited Vanguard Short-Term Corporate Bond ETF in Q3 2020, selling an estimated $34.1M.
- Jeff Yass's ten largest holdings make up 34% of its $522B portfolio in Q3 2020.
- Jeff Yass opened 1,567 new positions and closed 1,138 in Q3 2020.
- Jeff Yass's portfolio value rose 26% quarter-over-quarter to $522B.
Based on Susquehanna International Group's 13F filing for Q3 2020, filed 16 Nov 2020.